Summit Therapeutics Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Miami, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Summit Therapeutics Inc. has filed 549 SEC EDGAR filings since 04 Mar 2014

SEC filing history

Showing 101-125 of 549 matching filings.

Per page
25
Current page
5
4

FORM 4

Filing date
13 Sep 2024
Reporting date
11 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Aug 2024
Reporting date
23 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Aug 2024
Reporting date
23 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-281273

S-3ASR

Filing date
06 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Jun 2024
Reporting date
27 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
27 Jun 2024
Reporting date
27 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-516356

D filing

Filing date
18 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36866

DEFA14A

Filing date
13 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-277169

424B5

Filing date
13 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-279024

INITIAL REGISTRATION STATEMENT

Filing date
01 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36866

DEF 14A

Filing date
25 Apr 2024
Reporting date
14 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Apr 2024
Reporting date
11 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .